CLSI M57
Principles and Procedures for the Development of Epidemiological Cutoff Values for Antifungal Susceptibility Testing
active, Most Current
Buy Now
| Organization: | CLSI |
| Publication Date: | 1 April 2016 |
| Status: | active |
| Page Count: | 28 |
scope:
This guideline specifies requirements and recommendations for developing and using epidemiological cutoff values (ECVs) in antifungal susceptibility testing.
The guideline's intended users are developers of ECVs for antifungal agents, laboratory directors who provide assistance to clinicians on interpreting antifungal minimal inhibitory concentration (MIC)/minimal effective concentration (MEC) values, and clinicians who interpret MIC/MEC values for the application of proper antifungal therapy and surveillance of emerging resistance.
- This guideline:
- Is not intended to provide an equivalent to breakpoint development
- Does not discuss breakpoint development
- Is not intended to provide a replacement for breakpoints
Document History
April 1, 2016
Principles and Procedures for the Development of Epidemiological Cutoff Values for Antifungal Susceptibility Testing
This guideline specifies requirements and recommendations for developing and using epidemiological cutoff values (ECVs) in antifungal susceptibility testing.
The guideline’s intended users are...
CLSI M57
April 1, 2016
Principles and Procedures for the Development of Epidemiological Cutoff Values for Antifungal Susceptibility Testing
This guideline specifies requirements and recommendations for developing and using epidemiological cutoff values (ECVs) in antifungal susceptibility testing.
The guideline’s intended users are...